Compliance with routine antenatal rhesus D prophylaxis and the impact on sensitisations: observations over 14 years.
Where this comes from
- Record sourced from PubMed, PMID 16827770.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Documented routine antenatal anti-D prophylaxis was given to 90% and 81-87% of eligible women at 28 and 34 weeks of gestation, respectively, during the early 1990s and early 2000s. With increasing experience and education, a significant improvement in the timing of the first (OR 0.26, 95% CI 0.16-0.41: P < 0.0001) and second injections (OR 0.40, 95% CI 0.26-0.61: P < 0.0001) occurred during the latter period. Despite these improvements, there was no reduction in the sensitisation rate at 0.4%. However, this low rate occurred despite significant proportions of women delivering more than 42 days after the second injection. Fifteen of the 16 sensitised women had received routine antenatal prophylaxis.
Medical subject headings
- Guideline Adherence
- Immunization
- Practice Guidelines as Topic
- Prenatal Care
- Rh Isoimmunization
- Rho(D) Immune Globulin